Bedford recalls Vecuronium Bromide for Injection at hospital/user-level

The voluntary recall is being conducted due to the discovery of particulate matter, which has been recognized as a potential health hazard, in a small number of vials within the lot.

The adverse reactions due to particulate matter may include vein irritation and phlebitis, clinically occult pulmonary granulomas detected at routine autopsy examination, local tissue infarction, pulmonary dysfunction, occlusion of capillaries and arteries, anaphylactic shock and death.

Vecuronium Bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.